Drug Profile
Sodium dichloroacetate
Alternative Names: Ceresine; CPC-211Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Michigan State University
- Developer Questcor Pharmaceuticals
- Class Acetates; Antineoplastics; Nootropics; Small molecules
- Mechanism of Action Pyruvate dehydrogenase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Craniocerebral trauma; Lactic acidosis; Spinal cord injuries; Stroke
Most Recent Events
- 13 Oct 2005 Discontinued - Clinical-Phase-Unknown for Lactic acidosis in USA (unspecified route)
- 13 Oct 2005 Discontinued - Phase-I for Head injuries in USA (IV)
- 13 Oct 2005 Discontinued - Phase-I for Head injuries in USA (PO)